Alkermes plc (ALKS)
NASDAQ·Healthcare·Biotechnology
$34.28
+1.63%
Mkt Cap $5.62B
Analyst Ratings
Buy
7
Hold
2
Sell
0
Price Target (24 analysts)
$47.25
Range $43.00 – $56.00
Implied Upside
+37.8%
Consensus $47.25 vs current $34.28
NASDAQ·Healthcare·Biotechnology
$34.28
+1.63%
Mkt Cap $5.62B
Buy
7
Hold
2
Sell
0
Price Target (24 analysts)
$47.25
Range $43.00 – $56.00
+37.8%
Consensus $47.25 vs current $34.28